Back
Corporate News
Aurobindo Pharma re-appointed Mangalam Kumar as Independent Director for a five-year term
04-Nov-2026, 10:04
Aurobindo Pharma Limited announced the re-appointment of Mangalam Ramasubramanian Kumar as a Non-executive and Independent Director for a second term of five years, effective April 1, 2027, subject to member approval via postal ballot. Kumar, whose current term expires on March 31, 2027, previously served as Chairman of LIC of India from March 2019 to March 2023 and is currently a director on the boards of Cholamandalam Investment and Finance Company Limited, Aurobindo Pharma Usa Inc., and Bank of India.
